IDX to acquire transcription firmIDX Systems has signed a definitive agreement to acquire medical transcription services firm EDiX. The deal is valued at $20 million plus the assumption of EDiX debt. Subject to regulatory and EDiX shareholder
IDX Systems has signed a definitive agreement to acquire medical transcription services firm EDiX. The deal is valued at $20 million plus the assumption of EDiX debt. Subject to regulatory and EDiX shareholder approval as well as satisfaction of other closing conditions, the transaction will be accounted for as a pooling of interests and is scheduled to close in the first quarter of 1999. n
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.